Andrea E. Schwaninger

发表

Identification of cytochrome P450 enzymes involved in the metabolism of the designer drugs N-(1-phenylcyclohexyl)-3-ethoxypropanamine and N-(1-phenylcyclohexyl)-3-methoxypropanamine.

M. Meyer, F. Peters, H. Maurer, 2008, Chemical research in toxicology.

Whole-cell biotransformation assay for investigation of the human drug metabolizing enzyme CYP3A7.

F. Peters, H. Maurer, M. Bureik, 2011, Biochimica et biophysica acta.

Development and validation of LC-HRMS and GC-NICI-MS methods for stereoselective determination of MDMA and its phase I and II metabolites in human urine.

M. Huestis, M. Meyer, H. Maurer, 2011, Journal of mass spectrometry : JMS.

Symptoms, toxicities, and analytical results for a patient after smoking herbs containing the novel synthetic cannabinoid MAM-2201

M. Liechti, A. Derungs, R. Bingisser, 2012, Forensic Toxicology.

Convenient Gram-Scale Metabolite Synthesis by Engineered Fission Yeast Strains Expressing Functional Human P450 Systems

P. Bour, F. Peters, H. Maurer, 2011, Applied biochemistry and biotechnology.

Investigation on the Enantioselectivity of the Sulfation of the Methylenedioxymethamphetamine Metabolites 3,4-Dihydroxymethamphetamine and 4-Hydroxy-3-Methoxymethamphetamine using the Substrate-Depletion Approach

M. Meyer, H. Maurer, Andrea E. Schwaninger, 2011, Drug Metabolism and Disposition.

Toxicology of Specific Substances

F. Musshoff, M. Thevis, W. Schänzer, 2014 .

Sulfation of the 3,4-methylenedioxymethamphetamine (MDMA) metabolites 3,4-dihydroxymethamphetamine (DHMA) and 4-hydroxy-3-methoxymethamphetamine (HMMA) and their capability to inhibit human sulfotransferases.

M. Meyer, H. Maurer, J. Zapp, 2011, Toxicology letters.

Qualitative studies on the metabolism and the toxicological detection of the fentanyl-derived designer drugs 3-methylfentanyl and isofentanyl in rats using liquid chromatography–linear ion trap–mass spectrometry (LC-MSn)

M. Meyer, J. Dinger, H. Maurer, 2011, Analytical and Bioanalytical Chemistry.

New cathinone-derived designer drugs 3-bromomethcathinone and 3-fluoromethcathinone: studies on their metabolism in rat urine and human liver microsomes using GC-MS and LC-high-resolution MS and their detectability in urine.

C. Vollmar, M. Meyer, E. Wolf, 2012, Journal of mass spectrometry : JMS.

Chiral drug analysis using mass spectrometric detection relevant to research and practice in clinical and forensic toxicology.

M. Meyer, H. Maurer, Andrea E. Schwaninger, 2012, Journal of chromatography. A.

Investigations on the cytochrome P450 (CYP) isoenzymes involved in the metabolism of the designer drugs N-(1-phenyl cyclohexyl)-2-ethoxyethanamine and N-(1-phenylcyclohexyl)-2-methoxyethanamine.

M. Meyer, F. Peters, H. Maurer, 2009, Biochemical pharmacology.

The Role of Human UDP-Glucuronyltransferases on the Formation of the Methylenedioxymethamphetamine (Ecstasy) Phase II Metabolites R- and S-3-Methoxymethamphetamine 4-O-Glucuronides

M. Meyer, H. Maurer, J. Zapp, 2009, Drug Metabolism and Disposition.

The Role of Human UDP-glucuronyltransferases on the Formation of the Methylenedioxymethamphetamine (Ecstasy) Phase II Metabolites R - and S -3-methoxymethamphetamine 4- O -glucuronides

M. Meyer, H. Maurer, J. Zapp, 2009 .

Investigations on the stereoselectivity of the phase II metabolism of the 3,4-methylenedioxyethylamphetamine (MDEA) metabolites 3,4-dihydroxyethylamphetamine (DHEA) and 4-hydroxy-3-methoxyethylamphetamine (HMEA).

M. Meyer, H. Maurer, J. Zapp, 2012, Toxicology letters.

Biotechnological synthesis of the designer drug metabolite 4'-hydroxymethyl-alpha-pyrrolidinohexanophenone in fission yeast heterologously expressing human cytochrome P450 2D6--a versatile alternative to multistep chemical synthesis.

F. Peters, H. Maurer, J. Zapp, 2009, Journal of analytical toxicology.

Use of fission yeast heterologously expressing human cytochrome P450 2B6 in biotechnological synthesis of the designer drug metabolite N-(1-phenylcyclohexyl)-2-hydroxyethanamine.

F. Peters, H. Maurer, J. Zapp, 2009, Forensic science international.

Phase II metabolism of 3,4-methylenedioxymethamphetamine : synthesis, analysis, and enantioselective in vitro and in vivo kinetics

Andrea E. Schwaninger, 2011 .

Urinary excretion kinetics of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and its phase I and phase II metabolites in humans following controlled MDMA administration.

M. Huestis, M. Meyer, D. Gorelick, 2011, Clinical chemistry.

Stereoselective urinary MDMA (ecstasy) and metabolites excretion kinetics following controlled MDMA administration to humans.

M. Huestis, M. Meyer, D. Gorelick, 2012, Biochemical pharmacology.

Human MDMA (Ecstasy) and Phase I and Phase II Metabolite Urinary Excretion Kinetics Following Controlled MDMA Administration

M. Huestis, M. Meyer, D. Gorelick, 2011 .